Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
97 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SANIFORT PHARMA from Leuven, company number BE0882765326, closed financial year 2025 with a result of € 75,588 after tax. For that financial year SANIFORT PHARMA recorded a gross margin of € 103,870 and equity of € -3.6 million. Compared with financial year 2024, the result moved from € 61,896 to € 75,588. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 28, 2026.
€ -3.6 million
▲ € 75,588 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 75,588
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 41,325
▼ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -3.8 million.
People and assets in 2025
€ 19,710
▼ 28% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,578
▲ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.5 million
▼ 3% vs 2024
€ 62,500 is repaid this year. At this pace the long-term loan is gone in ≈ 41 years.
€ 625,916
▼ 24% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,914
▲ 224% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -402,626 | € 88,039 | € 113,027 | € 103,870 | ▼ 8% |
| Profit after taxes | € -475,548 | € 13,858 | € 61,896 | € 75,588 | ▲ 22% |
| Equity | € -3,748,064 | € -3,734,206 | € -3,672,310 | € -3,596,722 | ▲ € 75,588 |
| Total debts | € 4,157,369 | € 4,288,751 | € 4,280,492 | € 4,005,147 | ▼ 6% |
| Cash | € 48,330 | € 32,800 | € 65,950 | € 41,325 | ▼ 37% |
| Retained profit | € -3,910,564 | € -3,896,706 | € -3,834,810 | € -3,759,222 | ▲ € 75,588 |
| Bank debt | € 2,724,175 | € 2,672,092 | € 2,624,592 | € 2,537,092 | ▼ 3% |
| Balance sheet total | € 409,305 | € 554,545 | € 608,182 | € 408,425 | ▼ 33% |
Key figures of SANIFORT PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to SANIFORT PHARMA?
What happened at SANIFORT PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 75,588 (▲ 22% vs 2024). Source: NBB ↗
- Leo Derieuw became a director. NBB
- Johan Jacobs became a director. NBB
- Karel Vandecasteele became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 475,548 loss in 2022 to € 75,588 profit in 2025.
Paid € 1,244 in corporate taxes since 2022.
Best year ever: 2025, with € 75,588 profit.
A new publication or filing at SANIFORT PHARMA? We notify you, reason included.
Follow SANIFORT PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SANIFORT PHARMA are Karel Vandecasteele, Leo Derieuw and Johan Jacobs. Karel Vandecasteele is also behind PE GROUP. Johan Jacobs is also behind ILJO CONSULT.
Directors
According to the 2025 annual accounts
since 2007
Leo Derieuw
Director
since 2009
since 2009
Establishments
Establishment units
Physical locations of this company
Interleuvenlaan 62
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 97 companies are registered at this address.
All companies at this address →SCHUT BELGIë
€ 33,349 gross margin · 2025
QUATTRO CLASSICS
€ 12,672 gross margin · 2025
Business Brewery
€ 385,638 gross margin · 2025
There
€ 487,247 gross margin · 2025
SWILLEN - NEESEN
+92 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0882.765.326
- VAT number
- BE 0882.765.326
- Registered office
- Interleuvenlaan 62, 3001 Leuven
- Names & denominations
- SANIFORT PHARMA · SP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 24 July 2006
- Peppol
- Active · Active since 29 Oct 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Groothandel in parfumerieën en cosmetica
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels